Hepatitis B - Annual Epidemiological Report for 2017
In 2017, 30 EU/EEA Member States reported 26 907 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 26 262, corresponds to a crude rate of 6.7 cases per 100 000 population. Of all cases, 9% were reported as acute, 58% as chronic, 32% as ‘unknown’ and 1% could not be classified. The highest rate of acute infections was observed among 35–44-year-olds, the highest rate of chronic infections among 25–34-year-olds. The overall male-to-female ratio was 1.6:1.
The rate of acute cases continues to decline, which is in accordance with global trends and most likely reflects the impact of national vaccination programmes. Among acute cases with complete information, heterosexual transmission was most commonly reported (27%), followed by nosocomial transmission (16%) and transmission among men who have sex with men (13%). Among chronic cases, mother-to-child transmission and nosocomial transmission were the most common routes of transmission reported (41% and 28% respectively).
Prevention and control programmes need further scaling up if European countries are to achieve the goal of eliminating hepatitis B. Surveillance data are important in monitoring the epidemiological situation, and there is a need to improve their quality.
See all annual epidemiological reports
Shiga toxin-producing Escherichia coli (STEC) infection - Annual Epidemiological Report for 2019
Hepatitis B is a liver disease that results from infection with the hepatitis B virus (HBV) and is spread through contact with infected body fluids or blood products.Read more
Annual Epidemiological Reports (AERs)
The Annual Epidemiological Reports (AERs) are key ECDC publication on the epidemiology of communicable diseases of public health significance in Europe. These reports give overviews of the epidemiology of communicable diseases of public health significance in Europe, drawn from surveillance information on the 52 communicable diseases and health issues for which surveillance is mandatory in the European Union (EU) and European Economic Area (EEA) countries.Read more
Hepatitis B - prevalence database
Prevalence data from sources such as population surveys can be a useful complement to case based surveillance data for hepatitis B. Case-based surveillance has limitations as most diagnosed cases are chronic in nature and detection of cases depends largely on testing practices. Prevalence data can therefore contribute towards a fuller understanding of the epidemiology of hepatitis B.Read more